These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 37944815)

  • 1. Opportunistic Salpingectomy Between 2017 and 2020: A Descriptive Analysis.
    Kaur P; Rufin K; Finlayson SJ; Huntsman DG; Kwon JS; McAlpine JN; Miller DM; Hanley GE
    J Obstet Gynaecol Can; 2024 Apr; 46(4):102278. PubMed ID: 37944815
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Opportunistic salpingectomy between 2011 and 2016: a descriptive analysis.
    Hanley GE; Niu J; Han J; Fung S; Bryant H; Kwon JS; Huntsman DG; Finlayson SJ; McAlpine JN; Miller D; Earle CC
    CMAJ Open; 2022; 10(2):E466-E475. PubMed ID: 35640988
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Extending the safety evidence for opportunistic salpingectomy in prevention of ovarian cancer: a cohort study from British Columbia, Canada.
    Hanley GE; Kwon JS; Finlayson SJ; Huntsman DG; Miller D; McAlpine JN
    Am J Obstet Gynecol; 2018 Aug; 219(2):172.e1-172.e8. PubMed ID: 29852159
    [TBL] [Abstract][Full Text] [Related]  

  • 4. No. 344-Opportunistic Salpingectomy and Other Methods of Risk Reduction for Ovarian/Fallopian Tube/Peritoneal Cancer in the General Population.
    Salvador S; Scott S; Francis JA; Agrawal A; Giede C
    J Obstet Gynaecol Can; 2017 Jun; 39(6):480-493. PubMed ID: 28527613
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The impact of opportunistic salpingectomy on ovarian cancer mortality and healthcare costs: a call for universal insurance coverage.
    Naumann RW; Hughes BN; Brown J; Drury LK; Herzog TJ
    Am J Obstet Gynecol; 2021 Oct; 225(4):397.e1-397.e6. PubMed ID: 33798477
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Opportunistic salpingectomy: uptake, risks, and complications of a regional initiative for ovarian cancer prevention.
    McAlpine JN; Hanley GE; Woo MM; Tone AA; Rozenberg N; Swenerton KD; Gilks CB; Finlayson SJ; Huntsman DG; Miller DM;
    Am J Obstet Gynecol; 2014 May; 210(5):471.e1-11. PubMed ID: 24412119
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Examining indicators of early menopause following opportunistic salpingectomy: a cohort study from British Columbia, Canada.
    Hanley GE; Kwon JS; McAlpine JN; Huntsman DG; Finlayson SJ; Miller D
    Am J Obstet Gynecol; 2020 Aug; 223(2):221.e1-221.e11. PubMed ID: 32067967
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cost-effectiveness of opportunistic salpingectomy vs tubal ligation at the time of cesarean delivery.
    Venkatesh KK; Clark LH; Stamilio DM
    Am J Obstet Gynecol; 2019 Jan; 220(1):106.e1-106.e10. PubMed ID: 30170036
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The performance and safety of bilateral salpingectomy for ovarian cancer prevention in the United States.
    Hanley GE; McAlpine JN; Pearce CL; Miller D
    Am J Obstet Gynecol; 2017 Mar; 216(3):270.e1-270.e9. PubMed ID: 27810554
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Paradigm shift from tubal ligation to opportunistic salpingectomy at cesarean delivery in the United States.
    Mandelbaum RS; Matsuzaki S; Sangara RN; Klar M; Matsushima K; Roman LD; Paulson RJ; Wright JD; Matsuo K
    Am J Obstet Gynecol; 2021 Oct; 225(4):399.e1-399.e32. PubMed ID: 34181896
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cost-effectiveness of opportunistic salpingectomy for ovarian cancer prevention.
    Dilley SE; Havrilesky LJ; Bakkum-Gamez J; Cohn DE; Michael Straughn J; Caughey AB; Rodriguez MI
    Gynecol Oncol; 2017 Aug; 146(2):373-379. PubMed ID: 28577884
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Complications after opportunistic salpingectomy compared with tubal ligation at cesarean section: a retrospective cohort study.
    Rufin KGA; do Valle HA; McAlpine JN; Elwood C; Hanley GE
    Fertil Steril; 2024 Mar; 121(3):531-539. PubMed ID: 38043843
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Outcomes From Opportunistic Salpingectomy for Ovarian Cancer Prevention.
    Hanley GE; Pearce CL; Talhouk A; Kwon JS; Finlayson SJ; McAlpine JN; Huntsman DG; Miller D
    JAMA Netw Open; 2022 Feb; 5(2):e2147343. PubMed ID: 35138400
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ovarian cancer prevention by opportunistic salpingectomy is a new de facto standard in Germany.
    Runnebaum IB; Kather A; Vorwergk J; Cruz JJ; Mothes AR; Beteta CR; Boer J; Keller M; Pölcher M; Mustea A; Sehouli J
    J Cancer Res Clin Oncol; 2023 Aug; 149(10):6953-6966. PubMed ID: 36847838
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Postpartum Opportunistic Salpingectomy Compared With Bilateral Tubal Ligation After Vaginal Delivery for Ovarian Cancer Risk Reduction: A Cost-Effectiveness Analysis.
    Wagar MK; Forlines GL; Moellman N; Carlson A; Matthews M; Williams M
    Obstet Gynecol; 2023 Apr; 141(4):819-827. PubMed ID: 36897130
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Postpartum Permanent Sterilization: Could Bilateral Salpingectomy Replace Bilateral Tubal Ligation?
    Danis RB; Della Badia CR; Richard SD
    J Minim Invasive Gynecol; 2016; 23(6):928-32. PubMed ID: 27234430
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tubal ligation and salpingectomy and the risk of epithelial ovarian cancer and borderline ovarian tumors: a nationwide case-control study.
    Madsen C; Baandrup L; Dehlendorff C; Kjaer SK
    Acta Obstet Gynecol Scand; 2015 Jan; 94(1):86-94. PubMed ID: 25256594
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Opportunistic bilateral salpingectomy during gynaecological surgery for benign disease: A survey of current Australian practice.
    Kapurubandara S; Qin V; Gurram D; Anpalagan A; Merkur H; Hogg R; Brand A
    Aust N Z J Obstet Gynaecol; 2015 Dec; 55(6):606-11. PubMed ID: 26768958
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Role of Opportunistic Bilateral Salpingectomy vs Tubal Occlusion or Ligation for Ovarian Cancer Prophylaxis.
    Ely LK; Truong M
    J Minim Invasive Gynecol; 2017; 24(3):371-378. PubMed ID: 28087480
    [TBL] [Abstract][Full Text] [Related]  

  • 20. ACOG Committee Opinion No. 774 Summary: Opportunistic Salpingectomy as a Strategy for Epithelial Ovarian Cancer Prevention.
    Obstet Gynecol; 2019 Apr; 133(4):842-843. PubMed ID: 30913193
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.